{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-07-12T23:27:23.950955+00:00","company":{"ticker":"CCTC","cik":1477960,"company_name":"LataMed AI Corp."},"pagination":{"limit":100,"returned":15,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"contract_counterparty":[{"display_name":"Kevin Rodan Levy","detail":"asset_purchase","count":3,"first_seen":"2026-04-13T23:59:59+00:00","last_seen":"2026-04-13T23:59:59+00:00","evidence_fact_ids":[24889,24890,24891]}],"ma_counterparty":[{"display_name":"Kevin Rodan Levy","detail":"acquisition","count":2,"first_seen":"2026-02-25T23:59:59+00:00","last_seen":"2026-04-13T23:59:59+00:00","evidence_fact_ids":[23725,24643]}]},"facts":[{"fact_type":"governance_change","fact_key":"cea4c731071ab6ea205528b64dcd73efc4509c60","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2026-05-08T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2026-05-06","item_codes_triggered":["5.03"],"summary_text":"Designated a new series of preferred stock, Series C Voting Preferred Stock, and filed a Certificate of Designation."},"claim":"LataMed AI Corp.: Designated a new series of preferred stock, Series C Voting Preferred Stock, and filed a Certificate of Designation (effective 2026-05-06).","evidence_excerpt":"On May 6, 2026, the Board of Directors of LataMed AI Corp. (formerly Catalyst Crew Technologies Corp.) (the “Company”) approved the designation of a new series of preferred stock designated as the “Series C Voting Preferred Stock” and filed a Certificate of Designation with the Nevada Secretary of State establishing the rights, preferences, and limitations of such series.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-002848","anchor_url":"https://secwatch.observer/filing/0001477932-26-002848#claim-cea4c731071ab6ea205528b64dcd73efc4509c60","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793226002848/0001477932-26-002848-index.htm"},{"fact_type":"governance_change","fact_key":"71fcf805436ef45ff6c62df13e0037d5e151a80d","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2026-05-04T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2026-04-28","item_codes_triggered":["5.03"],"summary_text":"Changed corporate name from Catalyst Crew Technologies Corp. to LataMed AI Corp."},"claim":"LataMed AI Corp.: Changed corporate name from Catalyst Crew Technologies Corp. to LataMed AI Corp (effective 2026-04-28).","evidence_excerpt":"On April 28, 2026, Catalyst Crew Technologies Corp. (the “ Company ”) filed a Certificate of Amendment to its Articles of Incorporation (the “ Certificate of Amendment ”) with the Nevada Secretary of State, pursuant to Nevada Revised Statutes Sections 78.385 and 78.390, to change the Company’s corporate name from “Catalyst Crew Technologies Corp.” to “LataMed AI Corp.”","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-002735","anchor_url":"https://secwatch.observer/filing/0001477932-26-002735#claim-71fcf805436ef45ff6c62df13e0037d5e151a80d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793226002735/0001477932-26-002735-index.htm"},{"fact_type":"material_agreement","fact_key":"81d077add858c5a9885e26ee88d69a433656a37a","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2026-04-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Intellectual Property Assignment Agreement","agreement_type":"other","counterparty":"Kevin Rodan Levy","effective_date":"2026-04-07","item_codes_triggered":["1.01"],"value_text":null},"claim":"LataMed AI Corp. entered into Intellectual Property Assignment Agreement with Kevin Rodan Levy (effective 2026-04-07).","evidence_excerpt":"On April 7, 2026, the Seller entered into an Intellectual Property Assignment Agreement with the Subsidiary, pursuant to which certain intellectual property rights previously acquired by the Company pursuant to the APA were formally assigned to the Subsidiary, including:","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-002171","anchor_url":"https://secwatch.observer/filing/0001477932-26-002171#claim-81d077add858c5a9885e26ee88d69a433656a37a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793226002171/0001477932-26-002171-index.htm"},{"fact_type":"material_agreement","fact_key":"917815692c1a391dd50473df94b4eaaccb95cf37","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2026-04-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Share Assignment Agreement","agreement_type":"asset_purchase","counterparty":"Kevin Rodan Levy","effective_date":"2026-03-23","item_codes_triggered":["1.01"],"value_text":null},"claim":"LataMed AI Corp. entered into Share Assignment Agreement with Kevin Rodan Levy (effective 2026-03-23).","evidence_excerpt":"On March 23, 2026, the Company entered into a Share Assignment Agreement with Seller pursuant to which the Company acquired one hundred percent (100%) of the issued and outstanding shares of Inversiones Long 33, C.A., a corporation organized under the laws of the Bolivarian Republic of Venezuela (the “Subsidiary”).","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-002171","anchor_url":"https://secwatch.observer/filing/0001477932-26-002171#claim-917815692c1a391dd50473df94b4eaaccb95cf37","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793226002171/0001477932-26-002171-index.htm"},{"fact_type":"material_agreement","fact_key":"08f1ab1632a7f67848aecd3aeacb7c9a7bfe7600","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2026-04-13T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Asset Purchase Agreement","agreement_type":"asset_purchase","counterparty":"Kevin Rodan Levy","effective_date":"2026-02-17","item_codes_triggered":["1.01"],"value_text":null},"claim":"LataMed AI Corp. entered into Asset Purchase Agreement with Kevin Rodan Levy (effective 2026-02-17).","evidence_excerpt":"On February 17, 2026, Catalyst Crew Technologies Corp. (the “Company”) entered into an Asset Purchase Agreement (the “APA”) with its Chief Executive Officer, Kevin Rodan Levy (the “Seller”), pursuant to which the Company acquired certain assets, including intellectual property relating to an artificial intelligence-enabled healthcare analytics platform.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-002171","anchor_url":"https://secwatch.observer/filing/0001477932-26-002171#claim-08f1ab1632a7f67848aecd3aeacb7c9a7bfe7600","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793226002171/0001477932-26-002171-index.htm"},{"fact_type":"ma_transaction","fact_key":"e8482091b7ba0645f6095baba9641a45082cf3ae","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2026-04-13T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2026-03-23","consideration_text":null,"counterparty":"Kevin Rodan Levy","effective_date":"2026-03-23","item_codes_triggered":["2.01"]},"claim":"LataMed AI Corp. completed an acquisition involving Kevin Rodan Levy (closed 2026-03-23).","evidence_excerpt":"On March 23, 2026, the Company completed the acquisition of one hundred percent (100%) of the issued and outstanding shares of Inversiones Long 33, C.A. pursuant to a Share Assignment Agreement with Kevin Rodan Levy.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-002171","anchor_url":"https://secwatch.observer/filing/0001477932-26-002171#claim-e8482091b7ba0645f6095baba9641a45082cf3ae","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793226002171/0001477932-26-002171-index.htm"},{"fact_type":"governance_change","fact_key":"bb2edbb6a890038584138bca96931373ff13509f","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2026-02-25T23:59:59+00:00","payload":{"change_type":"shell_status","effective_date":null,"item_codes_triggered":["5.06"],"summary_text":"Company ceased to be a shell company upon completion of an asset acquisition"},"claim":"LataMed AI Corp.: Company ceased to be a shell company upon completion of an asset acquisition.","evidence_excerpt":"As a result of the completion of the acquisition of the assets described in Item 2.01 of this Current Report on Form 8-K, the Company is no longer a shell company.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-001029","anchor_url":"https://secwatch.observer/filing/0001477932-26-001029#claim-bb2edbb6a890038584138bca96931373ff13509f","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793226001029/0001477932-26-001029-index.htm"},{"fact_type":"ma_transaction","fact_key":"9e0f00b40d713760c4fbf45add6a5a76e2b607c6","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2026-02-25T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2026-02-17","consideration_text":"12,000,000 shares of restricted common stock, par value $0.0001 per share","counterparty":"Kevin Rodan Levy","effective_date":"2026-02-17","item_codes_triggered":["2.01","5.01"]},"claim":"LataMed AI Corp. completed an acquisition involving Kevin Rodan Levy for 12,000,000 shares of restricted common stock, par value $0.0001 per share (closed 2026-02-17).","evidence_excerpt":"property (collectively, the “Acquired Assets”). As consideration for the acquisition of the Acquired Assets, the Company agreed to issue to the Seller Twelve Million (12,000,000) shares of the Company’s restricted common stock, par value $0.0001 per share (the “Purchase Shares”). The Purchase Shares were issued at par value and are subject to","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-26-001029","anchor_url":"https://secwatch.observer/filing/0001477932-26-001029#claim-9e0f00b40d713760c4fbf45add6a5a76e2b607c6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793226001029/0001477932-26-001029-index.htm"},{"fact_type":"executive_change","fact_key":"98845c44ff","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2024-11-12T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-11-06","interim":false,"role":"Chief Executive Officer, President, Chief Financial Officer, Treasurer, Secretary, Chairman","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Waqas Nakhwa was appointed as Chief Executive Officer, President, Chief Financial Officer, Treasurer, Secretary, Chairman at LataMed AI Corp..","evidence_excerpt":"On November 6, 2024 (the “Effective Date”), the Company entered into an employment agreement with Mr. Waqas Nakhwa in connection with his appointment as Chief Executive Officer, President, Chief Financial Officer, Treasurer, Secretary, and as Chairman of the Company’s Board of Directors","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001477932-24-007001","anchor_url":"https://secwatch.observer/filing/0001477932-24-007001#claim-98845c44ff","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793224007001/0001477932-24-007001-index.htm"},{"fact_type":"executive_change","fact_key":"cfcd86424a","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2024-06-14T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-06-07","interim":false,"role":"Independent Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Vineet Jawa was appointed as Independent Director at LataMed AI Corp..","evidence_excerpt":"Additionally, on June 7, 2024, the Company appointed Mr. Vineet Jawa to serve as an independent member of the Corporation’s Board of Directors to serve until the next annual meeting of the Corporation or until his respective successor is duly appointed.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001477932-24-003696","anchor_url":"https://secwatch.observer/filing/0001477932-24-003696#claim-cfcd86424a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793224003696/0001477932-24-003696-index.htm"},{"fact_type":"executive_change","fact_key":"c10cfe0403","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2024-06-14T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"Independent Director","role_category":"director","successor_name":"Vineet Jawa","successor_named":true},"claim":"Sameer Kudsia resigned as Independent Director at LataMed AI Corp..","evidence_excerpt":"On June 4, 2024, the Corporation received notice of resignation from Mr. Sameer Kudsia (“Mr. Kudsia”) as an Independent Director of the Company.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-24-003696","anchor_url":"https://secwatch.observer/filing/0001477932-24-003696#claim-c10cfe0403","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793224003696/0001477932-24-003696-index.htm"},{"fact_type":"executive_change","fact_key":"0bd6a8cdf9","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2024-06-14T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-06-07","interim":false,"role":"President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary, Chairman","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Waqas Nakhwa was appointed as President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary, Chairman at LataMed AI Corp..","evidence_excerpt":"Effective immediately upon the resignation of Ms. Kaur, the Corporation appointed Mr. Waqas Nakhwa to serve as President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary, and Chairman of the Corporation’s Board of Directors to serve until the next annual meeting of the Corporation or until his respective successor is duly appointed.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001477932-24-003696","anchor_url":"https://secwatch.observer/filing/0001477932-24-003696#claim-0bd6a8cdf9","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793224003696/0001477932-24-003696-index.htm"},{"fact_type":"executive_change","fact_key":"83dd32280c","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2024-06-14T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":"2024-06-07","interim":false,"role":"President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary, Director","role_category":"ceo","successor_name":"Waqas Nakhwa","successor_named":true},"claim":"Gurneet Kaur resigned as President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary, Director at LataMed AI Corp..","evidence_excerpt":"On June 7, 2024, the Company received notice of resignation from Ms. Gurneet Kaur from the positions of President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary, and Director of the Corporation.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001477932-24-003696","anchor_url":"https://secwatch.observer/filing/0001477932-24-003696#claim-83dd32280c","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793224003696/0001477932-24-003696-index.htm"},{"fact_type":"auditor_change","fact_key":"2b519d9b12f9999bf99f9cdea3de154a48f6628e","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2024-03-14T23:59:59+00:00","payload":{"action":"engagement","auditor_name":"Beckles & Co, Inc.","disagreement_text":null,"effective_date":"2024-03-12","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"LataMed AI Corp. engaged Beckles & Co, Inc. as its auditor.","evidence_excerpt":"On March 12, 2024, the Company appointed Beckles & Co, Inc. CPA (“Beckles & Co.”) as the Company’s new independent registered public accounting firm effective as of March 12, 2024. The board of directors of the Company approved the appointment of Beckles. During the fiscal year ended December 31, 2022, and the period from September 30, 2023, through the date of Beckles & Co.’s appointment, neither the Company, nor anyone acting on its behalf, consulted with a regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that may be rendered on the Company’s financial statements, and Beckles & Co.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-24-001193","anchor_url":"https://secwatch.observer/filing/0001477932-24-001193#claim-2b519d9b12f9999bf99f9cdea3de154a48f6628e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793224001193/0001477932-24-001193-index.htm"},{"fact_type":"auditor_change","fact_key":"f2178745598a5c3902689432e6ba849d785540cb","cik":1477960,"ticker":"CCTC","company_name":"LataMed AI Corp.","filed_at":"2024-03-14T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"Gries & Associates, LLC","disagreement_text":null,"effective_date":"2024-03-12","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":"Beckles & Co, Inc."},"claim":"LataMed AI Corp. dismissed Gries & Associates, LLC as its auditor.","evidence_excerpt":"On March 12, 2024, the Company dismissed Gries & Associates, LLC (“Gries”) as the Company’s independent registered public accounting firm.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-24-001193","anchor_url":"https://secwatch.observer/filing/0001477932-24-001193#claim-f2178745598a5c3902689432e6ba849d785540cb","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1477960/000147793224001193/0001477932-24-001193-index.htm"}]}